Spotlight On Non-Melanoma Skin Cancer

Non-melanoma skin cancer (NMSC) is the most commonly diagnosed malignancy worldwide, with basal cell carcinoma and cutaneous squamous cell carcinoma accounting for the vast majority of cases. Many lesions are effectively managed with established treatment approaches, but advanced, high-risk, and recurrent disease continue to present meaningful clinical challenges.

That’s why ourSpotlight On Non-Melanoma Skin Cancer series provides timely, evidence-based insights across the evolving treatment landscape.